Metropolis Healthcare’s Credit Profile Gains Momentum, Crisil Maintains ‘AA-’ Rating And Lifts Outlook To ‘Positive’
Mumbai: Crisil Ratings has upgraded the outlook on Metropolis Healthcare Limited’s long-term bank facilities and non-convertible debentures to “positive” from “stable”, while reaffirming its credit rating at “Crisil AA-”. The agency retained its “Crisil A1+” rating on the company’s short-term bank facilities. GIC Housing Finance NCDs Secure ‘AA+’ Crisil Rating, Stable Outlook Signals Strong…
Mumbai: Credit rating agency Crisil has upgraded the outlook on Metropolis Healthcare Limited’s long-term bank facilities and non-convertible debentures, maintaining its AA- credit rating. The positive outlook is attributed to Metropolis Healthcare's stronger organic revenue growth, improved profitability, and higher cash accruals.
The company's expanded laboratory network, favorable mix of diagnostic tests, and improving profitability at its acquired Core Diagnostics Private Limited are expected to sustain healthy operating margins in the medium term. Recent acquisitions have bolstered the company's presence in north India, where its contribution to domestic revenue rose to 17 percent from 9 percent.
Metropolis Healthcare's revenue increased by 24 percent to ₹1,646 crore in FY26, driven by higher patient volumes and demand for specialized diagnostic and wellness tests under its TruHealth brand. The company's financial risk profile remains strong, with robust liquidity, an adjusted net worth of ₹1,335 crore as of March 31, 2026, and limited reliance on bank borrowings.
However, intense competition and moderate entry barriers continue to pose challenges for the company.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
